TRIOFLEX Trademark

Trademark Overview


On Monday, January 22, 2024, a trademark application was filed for TRIOFLEX with the United States Patent and Trademark Office. The USPTO has given the TRIOFLEX trademark a serial number of 98369555. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, August 21, 2024. This trademark is owned by Unipharm, Inc.. The TRIOFLEX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals and dietary supplements
trioflex

General Information


Serial Number98369555
Word MarkTRIOFLEX
Filing DateMonday, January 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceuticals and dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUnipharm, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10118

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NEW APPLICATION ENTERED
Wednesday, May 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2024ASSIGNED TO EXAMINER
Wednesday, August 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 21, 2024NON-FINAL ACTION E-MAILED